Memorandum of Understanding Between the Food and Drug Administration and Duke University, 65745-65749 [07-5793]
Download as PDF
<![CDATA[
65745
Federal Register / Vol. 72, No. 225 / Friday, November 23, 2007 / Notices
Additional Information:
Copies of the proposed collection may
be obtained by writing to the
Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. All requests should be
identified by the title of the information
collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment:
OMB is required to make a decision
concerning the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication. Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Fax: 202–395–6974,
Attn: Desk Officer for the
Administration for Children and
Families.
information on services provided
through the CCDF, which is required by
the CCDF Final Rule (45 FR parts 98 and
99). Tribal Lead Agencies (TLAs) are
required to submit annual aggregate data
appropriate to Tribal programs on
children and families receiving CCDFfunded child care services. The CCDF
statute and regulations also require
TLAs to submit a supplemental
narrative as part of the ACF–700 report.
This narrative describes general child
care activities and actions in the TLA’s
service area and is not restricted to
CCDF-funded child care activities.
Instead, this description is intended to
address all child care available in the
TLA’s service area. The ACF–700 and
supplemental narrative report will be
included in the Secretary’s report to
Congress, as appropriate, and will be
shared with all TLA’s to inform them of
CCDF-funded activities in other Tribal
programs.
Respondents: Tribal Governments.
Dated: November 14, 2007.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 07–5787 Filed 11–21–07; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Child Care and Development
Fund Tribal Annual Report (ACF–700
Report).
OMB No.: 0980–0241.
Description: The Child Care and
Development Fund (CCDF) report
requests annual Tribal aggregate
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
ACF–700 Report ..............................................................................................
260
1
38
9,880
........................
........................
........................
9,880.
mstockstill on PROD1PC66 with NOTICES
Estimated Total Annual Burden Hours: ....................................................
Additional Information:
Copies of the proposed collection may
be obtained by writing to the
Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. All requests should be
identified by the title of the information
collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment:
OMB is required to make a decision
concerning the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication. Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Fax: 202–395–6974,
Attn: Desk Officer for the
Administration for Children and
Families.
VerDate Aug<31>2005
16:16 Nov 21, 2007
Jkt 214001
Dated: November 15, 2007.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 07–5788 Filed 11–21–07; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[FDA 225–07–8005]
Memorandum of Understanding
Between the Food and Drug
Administration and Duke University
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
The agreement became effective
September, 22, 2007.
DATES:
FOR FURTHER INFORMATION CONTACT:
Melissa Robb, Office of Critical Path
Programs, Office of Scientific and
Medical Programs, Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–1516.
In
accordance with 21 CFR 20.108(c),
which states that all written agreements
and MOUs between FDA and others
shall be published in the Federal
Register, the agency is publishing notice
of this MOU.
SUPPLEMENTARY INFORMATION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is providing
notice of a memorandum of
understanding (MOU) between FDA and
Duke University. The purpose of this
MOU is to establish the terms of
collaboration between FDA and Duke,
beginning with an initiative to
strengthen Human Subjects Protection
PO 00000
by reexamining and modernizing the
conduct of clinical trials to ensure that
design, execution, and analysis are of
optimal quality. To this end, Duke will
be the convener of a Public Private
Partnership, to which FDA will be a
founding partner, to systematically
modernize the clinical trial process.
Frm 00048
Fmt 4703
Sfmt 4703
Dated: November 16, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
BILLING CODE 4160–01–P
E:\FR\FM\23NON1.SGM
23NON1
VerDate Aug<31>2005
Federal Register / Vol. 72, No. 225 / Friday, November 23, 2007 / Notices
16:16 Nov 21, 2007
Jkt 214001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4725
E:\FR\FM\23NON1.SGM
23NON1
EN23NO07.000</GPH>
mstockstill on PROD1PC66 with NOTICES
65746
VerDate Aug<31>2005
16:16 Nov 21, 2007
Jkt 214001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4725
E:\FR\FM\23NON1.SGM
23NON1
65747
EN23NO07.001</GPH>
mstockstill on PROD1PC66 with NOTICES
Federal Register / Vol. 72, No. 225 / Friday, November 23, 2007 / Notices
VerDate Aug<31>2005
Federal Register / Vol. 72, No. 225 / Friday, November 23, 2007 / Notices
16:16 Nov 21, 2007
Jkt 214001
PO 00000
Frm 00051
Fmt 4703
Sfmt 4725
E:\FR\FM\23NON1.SGM
23NON1
EN23NO07.002</GPH>
mstockstill on PROD1PC66 with NOTICES
65748
Federal Register / Vol. 72, No. 225 / Friday, November 23, 2007 / Notices
65749
BILLING CODE 4160–01–P
VerDate Aug<31>2005
17:43 Nov 21, 2007
Jkt 214001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
E:\FR\FM\23NON1.SGM
23NON1
EN23NO07.003</GPH>
mstockstill on PROD1PC66 with NOTICES
[FR Doc. 07–5793 Filed 11–21–07; 8:45 am]
]]>Agencies
[Federal Register Volume 72, Number 225 (Friday, November 23, 2007)]
[Notices]
[Pages 65745-65749]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-5793]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[FDA 225-07-8005]
Memorandum of Understanding Between the Food and Drug
Administration and Duke University
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is providing notice of
a memorandum of understanding (MOU) between FDA and Duke University.
The purpose of this MOU is to establish the terms of collaboration
between FDA and Duke, beginning with an initiative to strengthen Human
Subjects Protection by reexamining and modernizing the conduct of
clinical trials to ensure that design, execution, and analysis are of
optimal quality. To this end, Duke will be the convener of a Public
Private Partnership, to which FDA will be a founding partner, to
systematically modernize the clinical trial process.
DATES: The agreement became effective September, 22, 2007.
FOR FURTHER INFORMATION CONTACT: Melissa Robb, Office of Critical Path
Programs, Office of Scientific and Medical Programs, Food and Drug
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1516.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which
states that all written agreements and MOUs between FDA and others
shall be published in the Federal Register, the agency is publishing
notice of this MOU.
Dated: November 16, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
BILLING CODE 4160-01-P
[[Page 65746]]
[GRAPHIC] [TIFF OMITTED] TN23NO07.000
[[Page 65747]]
[GRAPHIC] [TIFF OMITTED] TN23NO07.001
[[Page 65748]]
[GRAPHIC] [TIFF OMITTED] TN23NO07.002
[[Page 65749]]
[GRAPHIC] [TIFF OMITTED] TN23NO07.003
[FR Doc. 07-5793 Filed 11-21-07; 8:45 am]
BILLING CODE 4160-01-P
